NorthRock Partners’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,251
Closed -$761K 690
2025
Q3
$761K Buy
11,251
+1,518
+16% +$110K 0.01% 411
2025
Q2
$725K Buy
9,733
+2,512
+35% +$167K 0.02% 310
2025
Q1
$454K Buy
7,221
+898
+14% +$55.5K 0.02% 368
2024
Q4
$360K Sell
6,323
-493
-7% -$29.2K 0.01% 425
2024
Q3
$401K Buy
6,816
+763
+13% +$41.7K 0.01% 419
2024
Q2
$326K Buy
6,053
+141
+2% +$7.76K 0.01% 448
2024
Q1
$341K Buy
5,912
+1,538
+35% +$79.4K 0.01% 451
2023
Q4
$210K Buy
+4,374
New +$209K 0.01% 540

Other funds holding CTVA

NorthRock Partners's CTVA Position: Q4 2025 in Review

NorthRock Partners sold out of Corteva (CTVA) in Q4 2025, closing a stake of 11,251 shares — an estimated $761K sold.

NorthRock Partners first reported a position in CTVA in Q4 2023 and held it in 8 quarters. The position peaked at $761K in Q3 2025. 1,425 funds tracked by Wall St. Rank hold CTVA as of Q4 2025.

  • NorthRock Partners reported no remaining Corteva position as of Q4 2025 after selling out during the quarter.
  • NorthRock Partners sold 11,251 Corteva shares in Q4 2025, an estimated $761K.
  • NorthRock Partners first reported a position in Corteva in Q4 2023 and held it in 8 quarters.
  • NorthRock Partners's Corteva position peaked at $761K in Q3 2025.
  • 1,425 funds tracked by Wall St. Rank held Corteva as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.